EIB to fund new vaccine production plant
The European Investment Bank (EIB) is planning to lend around Euro 40m to Germany's Impfstoffwerk Dessau-Tornau to help it build a new research and development building and a new production facility for virus vaccines.
The European Investment Bank (EIB) is planning to lend around Euro 40m to Germany's Impfstoffwerk Dessau-Tornau to help it build a new research and development building and a new production facility for virus vaccines.
The loan would also part-fund the reconstruction of a filling unit, the expansion of existing cooling, storage and vaccine production facilities plus investments in equipment.
The overall cost of these projects is estimated at €100m and will create 197 jobs in the company's eastern German region of Saxony-Anhalt, while safeguarding others at Impfstoffwerk, a medicine manufacturer specialising in immunobiologicals.